Annals of Neurology Annals of Neurology, Wiley, 2021, 89 (4), pp.686-697. ⟨10.1002/ana.26009⟩ Moisse, M, Zwamborn, R A J, van Vugt, J, van der Spek, R, van Rheenen, W, Kenna, B, Van Eijk, K, Kenna, K, Corcia, P, Couratier, P, Vourc'h, P, Hardiman, O, McLaughin, R, Gotkine, M, Drory, V, Ticozzi, N, Silani, V, de Carvalho, M, Mora Pardina, J S, Povedano, M, Andersen, P M, Weber, M, Başak, N A, Chen, X, Eberle, M A, Al-Chalabi, A, Shaw, C, Shaw, P J, Morrison, K E, Landers, J E, Glass, J D, Robberecht, W, van Es, M, van den Berg, L, Veldink, J & Van Damme, P 2021, ' The Effect of SMN Gene Dosage on ALS Risk and Disease Severity ', Annals of neurology, vol. 89, no. 4, pp. 686-697 . https://doi.org/10.1002/ana.26009
Dipòsit Digital de la UB Universidad de Barcelona Brain Communications Brain Communications, Oxford University Press on behalf of the Guarantors of Brain, 2020, 2 (2), ⟨10.1093/braincomms/fcaa064⟩